We suspect that AIG will live on as a litigant long after the company is dead and gone. In the latest development, defendants in a long-running Delaware derivative suit are asked to be dismissed from the case.

An already hot case just got a little hotter. Huntsman is suing the banks that backed out of financing its merger with Hexion for billions. Hexion's parent, Apollo, is supposed to be helping Huntsman. But now the banks have roped Apollo's founders in as third-party defendants. We can't wait til the June trial date!

For litigators, it pays to be both tenacious and creative. For evidence, look no further than William Isaacson's long antitrust crusade against Chinese vitamin C manufacturers, which culminated this month in an historic $162 million jury verdict.

Can Chinese companies that allegedly fixed prices for U.S. customers deflect liability by saying they acted at their government's behest? Jurors may get a chance to answer that question beginning Monday, when an antitrust class action trial against a group of Chinese vitamin manufacturers opens in U.S. district court in Brooklyn.

Another big bank has entered into a multi-million dollar settlement with federal and state authorities investigating bid-rigging in the municipal bond market. And for once, the settlement isn't likely to draw opposition from plaintiffs lawyers in parallel multidistrict litigation worried that the deal will sideline class claims.